These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24934552)

  • 1. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.
    Foglietta F; Serpe L; Canaparo R; Vivenza N; Riccio G; Imbalzano E; Gasco P; Zara GP
    J Pharm Pharm Sci; 2014; 17(2):231-47. PubMed ID: 24934552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells.
    Serpe L; Laurora S; Pizzimenti S; Ugazio E; Ponti R; Canaparo R; Briatore F; Barrera G; Gasco MR; Bernengo MG; Eandi M; Zara GP
    Anticancer Drugs; 2004 Jun; 15(5):525-36. PubMed ID: 15166628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
    Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
    Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved In Vitro Antileukemic Activity of All-Trans Retinoic Acid Loaded in Cholesteryl Butyrate Solid Lipid Nanoparticles.
    Silva EL; Lima FA; Carneiro G; Ramos Jonas Periera ; Gomes DA; de Souza-Fagundes EM; Ferreira LA
    J Nanosci Nanotechnol; 2016 Feb; 16(2):1291-300. PubMed ID: 27433579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
    Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer cells.
    Andrade FO; Nagamine MK; Conti AD; Chaible LM; Fontelles CC; Jordão Junior AA; Vannucchi H; Dagli ML; Bassoli BK; Moreno FS; Ong TP
    Braz J Med Biol Res; 2012 Sep; 45(9):841-50. PubMed ID: 22714808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells.
    Shin H; Lee YS; Lee YC
    Oncol Rep; 2012 Apr; 27(4):1111-5. PubMed ID: 22160140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of butyrate analogues in HT-29 cancer cells.
    Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):482-9. PubMed ID: 19930426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing itraconazole to the benefit of skin cancer treatment: A combined azole-DDAB nanoencapsulation strategy.
    Carbone C; Martins-Gomes C; Pepe V; Silva AM; Musumeci T; Puglisi G; Furneri PM; Souto EB
    Colloids Surf B Biointerfaces; 2018 Jul; 167():337-344. PubMed ID: 29684903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.
    Batova A; Shao LE; Diccianni MB; Yu AL; Tanaka T; Rephaeli A; Nudelman A; Yu J
    Blood; 2002 Nov; 100(9):3319-24. PubMed ID: 12384433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase inhibitor sodium butyrate induces DNA topoisomerase II alpha expression and confers hypersensitivity to etoposide in human leukemic cell lines.
    Kurz EU; Wilson SE; Leader KB; Sampey BP; Allan WP; Yalowich JC; Kroll DJ
    Mol Cancer Ther; 2001 Dec; 1(2):121-31. PubMed ID: 12467229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
    Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C
    Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitor sodium butyrate suppresses DNA double strand break repair induced by etoposide more effectively in MCF-7 cells than in HEK293 cells.
    Li L; Sun Y; Liu J; Wu X; Chen L; Ma L; Wu P
    BMC Biochem; 2015 Jan; 16():2. PubMed ID: 25592494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors.
    McBain JA; Eastman A; Nobel CS; Mueller GC
    Biochem Pharmacol; 1997 May; 53(9):1357-68. PubMed ID: 9214697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.
    Kibbie JJ; Dillon SM; Thompson TA; Purba CM; McCarter MD; Wilson CC
    Immunobiology; 2021 Sep; 226(5):152126. PubMed ID: 34365090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.
    Miao J; Du YZ; Yuan H; Zhang XG; Hu FQ
    Colloids Surf B Biointerfaces; 2013 Oct; 110():74-80. PubMed ID: 23711779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophilic differentiation modulates the apoptotic response of HL-60 cells to sodium butyrate and sodium valproate.
    Vrba J; Dolezel P; Ulrichova J
    Neoplasma; 2010; 57(5):438-48. PubMed ID: 20568898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.